Neuropeptide Y secretion from a malignant extraadrenal retroperitoneal paraganglioma

Cancer. 1992 Nov 1;70(9):2350-3. doi: 10.1002/1097-0142(19921101)70:9<2350::aid-cncr2820700923>3.0.co;2-8.

Abstract

A patient with a malignant extraadrenal retroperitoneal paraganglioma had elevated levels of immunoreactive neuropeptide Y (NPY) in the peripheral blood (5988 pg/ml; normal, 123 +/- 30 pg/ml [mean +/- standard error of the mean]). A 6-month course of chemotherapy allowed surgical removal of the previously unresectable primary tumor. Postoperatively, the plasma NPY level initially fell to 1089 pg/ml; continued chemotherapy caused an additional decrease to 440 pg/ml. Four months after surgery, the plasma NPY level increased to 940 mg/ml, coincident with hepatic metastases. This case is the first report of a NPY-secreting clinically nonfunctional malignant extraadrenal paraganglioma. Determination of circulating NPY levels may be useful in the diagnosis and follow-up of patients with neuroendocrine tumors.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Middle Aged
  • Neoplasm Invasiveness
  • Neuropeptide Y / blood*
  • Neuropeptide Y / metabolism
  • Paraganglioma, Extra-Adrenal / blood*
  • Paraganglioma, Extra-Adrenal / metabolism
  • Paraganglioma, Extra-Adrenal / pathology
  • Paraganglioma, Extra-Adrenal / secondary
  • Peritoneal Neoplasms / secondary
  • Retroperitoneal Neoplasms / blood*
  • Retroperitoneal Neoplasms / metabolism
  • Retroperitoneal Neoplasms / pathology

Substances

  • Neuropeptide Y